Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations
2005 ◽
Vol 16
(10)
◽
pp. 3027-3037
◽
2012 ◽
Vol 14
(1)
◽
pp. 67-73
◽
2013 ◽
Vol 7
(1)
◽
pp. 11-20
◽
2015 ◽
Vol 9
(2)
◽
pp. 45-50
◽
2005 ◽
Vol 68
(1)
◽
pp. 193-205
◽
2002 ◽
Vol 15
(S5)
◽
pp. 108S-114S
◽